List of Tables
    Table 1. Gastrointestinal Cancer Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Gastrointestinal Cancer Drugs Market Trends
    Table 3. Gastrointestinal Cancer Drugs Market Drivers
    Table 4. Gastrointestinal Cancer Drugs Market Challenges
    Table 5. Gastrointestinal Cancer Drugs Market Restraints
    Table 6. Global Gastrointestinal Cancer Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Gastrointestinal Cancer Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Gastrointestinal Cancer Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Gastrointestinal Cancer Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Gastrointestinal Cancer Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Gastrointestinal Cancer Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Gastrointestinal Cancer Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Gastrointestinal Cancer Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Gastrointestinal Cancer Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Gastrointestinal Cancer Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Gastrointestinal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Gastrointestinal Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Drugs as of 2021)
    Table 18. Top Players of Gastrointestinal Cancer Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Gastrointestinal Cancer Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Gastrointestinal Cancer Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Gastrointestinal Cancer Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Gastrointestinal Cancer Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Gastrointestinal Cancer Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Gastrointestinal Cancer Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Gastrointestinal Cancer Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Gastrointestinal Cancer Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Gastrointestinal Cancer Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Gastrointestinal Cancer Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Gastrointestinal Cancer Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Gastrointestinal Cancer Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Gastrointestinal Cancer Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Gastrointestinal Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Gastrointestinal Cancer Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Gastrointestinal Cancer Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Gastrointestinal Cancer Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Gastrointestinal Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Gastrointestinal Cancer Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Gastrointestinal Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Gastrointestinal Cancer Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Gastrointestinal Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Amgen & Amgen Ireland Corporation Information
    Table 43. Amgen & Amgen Ireland Description and Business Overview
    Table 44. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product
    Table 46. Amgen & Amgen Ireland Recent Development
    Table 47. Bristol-Myers Squibb Company Corporation Information
    Table 48. Bristol-Myers Squibb Company Description and Business Overview
    Table 49. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Bristol-Myers Squibb Company Product
    Table 51. Bristol-Myers Squibb Company Recent Development
    Table 52. Roche Corporation Information
    Table 53. Roche Description and Business Overview
    Table 54. Roche Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Roche Product
    Table 56. Roche Recent Development
    Table 57. Eli Lilly and Company Corporation Information
    Table 58. Eli Lilly and Company Description and Business Overview
    Table 59. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Eli Lilly and Company Product
    Table 61. Eli Lilly and Company Recent Development
    Table 62. Johnson & Johnson Private Corporation Information
    Table 63. Johnson & Johnson Private Description and Business Overview
    Table 64. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Johnson & Johnson Private Product
    Table 66. Johnson & Johnson Private Recent Development
    Table 67. GlaxoSmithKline Corporation Information
    Table 68. GlaxoSmithKline Description and Business Overview
    Table 69. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. GlaxoSmithKline Product
    Table 71. GlaxoSmithKline Recent Development
    Table 72. Celgene Corporation Corporation Information
    Table 73. Celgene Corporation Description and Business Overview
    Table 74. Celgene Corporation Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Celgene Corporation Product
    Table 76. Celgene Corporation Recent Development
    Table 77. Pfizer Corporation Information
    Table 78. Pfizer Description and Business Overview
    Table 79. Pfizer Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Pfizer Product
    Table 81. Pfizer Recent Development
    Table 82. Sanofi Corporation Information
    Table 83. Sanofi Description and Business Overview
    Table 84. Sanofi Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Sanofi Product
    Table 86. Sanofi Recent Development
    Table 87. Novartis Corporation Information
    Table 88. Novartis Description and Business Overview
    Table 89. Novartis Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Novartis Product
    Table 91. Novartis Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Gastrointestinal Cancer Drugs Customers List
    Table 95. Gastrointestinal Cancer Drugs Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastrointestinal Cancer Drugs Product Picture
    Figure 2. Global Gastrointestinal Cancer Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Gastrointestinal Cancer Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Gastrointestinal Cancer Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Gastrointestinal Cancer Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Gastrointestinal Cancer Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Gastrointestinal Cancer Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Gastrointestinal Cancer Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Gastrointestinal Cancer Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Gastrointestinal Cancer Drugs Report Years Considered
    Figure 11. Product Picture of Oncology
    Figure 12. Product Picture of Radiology
    Figure 13. Product Picture of Others
    Figure 14. Global Gastrointestinal Cancer Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Gastrointestinal Cancer Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Gastrointestinal Cancer Drugs Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Gastrointestinal Cancer Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Gastrointestinal Cancer Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Gastrointestinal Cancer Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Gastrointestinal Cancer Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Gastrointestinal Cancer Drugs Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Gastrointestinal Cancer Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Specialized Cancer Treatment Centers
    Figure 28. Product Picture of Clinics
    Figure 29. Product Picture of Ambulatory Surgical Centers
    Figure 30. Global Gastrointestinal Cancer Drugs Market Share by Application in 2022 & 2028
    Figure 31. Global Gastrointestinal Cancer Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Gastrointestinal Cancer Drugs Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Gastrointestinal Cancer Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Gastrointestinal Cancer Drugs Market Share by Application in 2022 & 2028
    Figure 37. United States Gastrointestinal Cancer Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Gastrointestinal Cancer Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Gastrointestinal Cancer Drugs Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Gastrointestinal Cancer Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Gastrointestinal Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Gastrointestinal Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Gastrointestinal Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Gastrointestinal Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Gastrointestinal Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Gastrointestinal Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Gastrointestinal Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Gastrointestinal Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Gastrointestinal Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Gastrointestinal Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Gastrointestinal Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Gastrointestinal Cancer Drugs Value Chain
    Figure 76. Gastrointestinal Cancer Drugs Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed